Sort

Search

Search Bar
04/04/2023 SUCNR1 signaling in adipocytes controls energy metabolism by modulating circadian clock and leptin expression
Villanueva-Carmona, T, Cedo, L, Madeira, A, Ceperuelo-Mallafre, V, Rodriguez-Pena, MM, Nunez-Roa, C, Maymo-Masip, E, Repolles-de-Dalmau, M, Badia, J, Keiran, N, Mirasierra, M, Pimenta-Lopes, C, Sabadell-Basallote, J, Bosch, R, Caubet, L, Escola-Gil, JC, Fernandez-Real, JM, Vilarrasa, N, Ventura, F, Vallejo, M, Vendrell, J, Fernandez-Veledo, S. SUCNR1 signaling in adipocytes controls energy metabolism by modulating circadian clock and leptin expression. Cell Metabolism. 2023; 35(4)DOI:10.1016/j.cmet.2023.03.004. PMID:36977414. IF:27.700(Q1/1D).
04/04/2023 ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia
Martin-Loeches, I, Torres, A, Nagavci, B, Aliberti, S, Antonelli, M, Bassetti, M, Bos, L, Chalmers, J, Derde, L, de Waele, J, Garnacho-Montero, J, Kollef, M, Luna, C, Menendez, R, Niederman, M, Ponomarev, D, Restrepo, M, Rigau, D, Schultz, M, Weiss, E, Welte, T, Wunderink, R. ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia. INTENSIVE CARE MEDICINE. 2023; 49(6)DOI:10.1007/s00134-023-07033-8. PMID:37012484. IF:29.600(Q1/1D).
03/04/2023 Phenotype and clinical outcomes of Glu89Lys hereditary transthyretin amyloidosis: a new endemic variant in Spain
de Frutos F., Ochoa J.P., Gómez-González C., Reyes-Leiva D., Aróstegui J.I., Casasnovas C., Barriales-Villa R., Sevilla T., Gonzalez-Lopez E., Ramil E., Galan L., González-Costello J., García-Álvarez A., Rojas-Garcia R., Espinosa M.A., Garcia-Pavia P.. Phenotype and clinical outcomes of Glu89Lys hereditary transthyretin amyloidosis: a new endemic variant in Spain. AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS. 2023; 30(2)DOI:10.1080/13506129.2022.2142110. PMID:36343383. IF:5.200(Q1/1D).
03/04/2023 ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia
Martin-Loeches, I, Torres, A, Nagavci, B, Aliberti, S, Antonelli, M, Bassetti, M, Bos, L, Chalmers, J, Derde, L, de Waele, J, Garnacho-Montero, J, Kollef, M, Luna, C, Menendez, R, Niederman, M, Ponomarev, D, Restrepo, M, Rigau, D, Schultz, M, Weiss, E, Welte, T, Wunderink, R. ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia. EUROPEAN RESPIRATORY JOURNAL. 2023; 61(4)DOI:10.1183/13993003.00735-2022. PMID:37012080. IF:17.000(Q1/1D).
03/04/2023 Critical Commentary on the paper: Compatibility of prolonged infusion antibiotics during Y-site administration with parenteral nutrition
De Pourcq J.T., Riera P.. Critical Commentary on the paper: Compatibility of prolonged infusion antibiotics during Y-site administration with parenteral nutrition. Nursing in Critical Care. 2023; 28(6)DOI:10.1111/nicc.12910. PMID:37232328. IF:3.000(Q1/1D).
03/04/2023 The role of precision medicine in bronchiectasis: emerging data and clinical implications
Oscullo G., de la Rosa D., Clemente, MG, Giron R., Golpe R., Máiz L., Martinez-Garcia M.A.. The role of precision medicine in bronchiectasis: emerging data and clinical implications. Expert Review of Respiratory Medicine. 2023; 17(4)DOI:10.1080/17476348.2023.2205125. PMID:37077039. IF:2.900(Q2/4D).
03/04/2023 Low complement levels are related to poor obstetric outcomes in women with obstetric antiphospholipid syndrome. The EUROAPS Registry Study Group
Esteve-Valverde E., Alijotas-Reig J., Belizna C., Marques-Soares J., Anunciacion-Llunell A., Feijóo-Massó C., Sáez-Comet L., Mekinian A., Ferrer-Oliveras R., Lefkou E., Morales-Pérez S., Hoxha A., Tincani A., Nalli C., Pardos-Gea J., Marozio L., Maina A., Espinosa G., Cervera R., De Carolis S., Latino O., Udry S., Llurba E., Garrido-Gimenez C., Trespidi L., Gerosa M., Chighizola C.B., Rovere-Querini P., Canti V., Mayer-Pickel K., Tabacco S., Arnau A., Miró-Mur F.. Low complement levels are related to poor obstetric outcomes in women with obstetric antiphospholipid syndrome. The EUROAPS Registry Study Group. PLACENTA. 2023; 136DOI:10.1016/j.placenta.2023.04.001. PMID:37028222. IF:3.000(Q1/3D).
01/04/2023 Characterizing SOD1 mutations in Spain: The impact of genotype, age and sex in the natural history of the disease
Vazquez-Costa, JF, Borrego-Hernandez, D, Paradas, C, Gomez-Caravaca, MT, Rojas-Garcia, R, Varona, L, Povedano, M, Garcia-Sobrino, T, Pascual, IJ, Gutierrez, A, Riancho, J, Turon-Sans, J, Assialioui, A, Perez-Tur, J, Sevilla, T, Perez, JE, Garcia-Redondo, A. Characterizing SOD1 mutations in Spain: The impact of genotype, age and sex in the natural history of the disease. EUROPEAN JOURNAL OF NEUROLOGY. 2023; 30(4)DOI:10.1111/ene.15661. PMID:36484631. IF:4.500(Q1/2D).